Paper33510482
Natural products in drug discovery: advances and opportunities.
Atanasov AG and 4 others. Nat Rev Drug Discov, 2021. Cited by 3,505 papers, by iCite.
Cite this record
ConductScience Library. Natural products in drug discovery: advances and opportunities. Papers, record 33510482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33510482
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biological Products | Major topic |
| Communicable Diseases | |
| Drug Discovery | |
| Drug Industry | |
| Genome | |
| Humans | |
| Neoplasms |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| MC_UU_12011/4 | Medical Research Council | United Kingdom | PubMed | PubMed | |
| P 25971 | Austrian Science Fund FWF | Austria | PubMed | PubMed | |
| P 27682 | Austrian Science Fund FWF | Austria | PubMed | PubMed | |
| P 32109 | Austrian Science Fund FWF | Austria | PubMed | PubMed | |
| G12MD007591 | NIH | NIH RePORTER | |||
| R01AG066749 | NIH | NIH RePORTER | |||
| U24AG047867 | NIH | NIH RePORTER |
References192
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26281720 | Discovery and resupply of pharmacologically active plant-derived natural products: A review. | Biotechnol Adv | 2015 | https://conductscience.org/library/papers/26281720 | PubMed |
| 2 | 25614221 | The re-emergence of natural products for drug discovery in the genomics era. | Nat Rev Drug Discov | 2015 | https://conductscience.org/library/papers/25614221 | PubMed |
| 3 | 26852623 | Natural Products as Sources of New Drugs from 1981 to 2014. | J Nat Prod | 2016 | https://conductscience.org/library/papers/26852623 | PubMed |
| 4 | 30315270 | Treatment of multiple sclerosis - success from bench to bedside. | Nat Rev Neurol | 2019 | https://conductscience.org/library/papers/30315270 | PubMed |
| 5 | 12546556 | Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. | J Chem Inf Comput Sci | 2003 | https://conductscience.org/library/papers/12546556 | PubMed |
| 6 | 26739749 | The use of isolated natural products as scaffolds for the generation of chemically diverse screening libraries for drug discovery. | Nat Prod Rep | 2016 | https://conductscience.org/library/papers/26739749 | PubMed |
| 7 | 19589993 | Drug discovery and natural products: end of an era or an endless frontier? | Science | 2009 | https://conductscience.org/library/papers/19589993 | PubMed |
| 8 | 15602548 | Lessons from natural molecules. | Nature | 2004 | https://conductscience.org/library/papers/15602548 | PubMed |
| 9 | 29140691 | Importance of Rigidity in Designing Small Molecule Drugs To Tackle Protein-Protein Interactions (PPIs) through Stabilization of Desired Conformers. | J Med Chem | 2018 | https://conductscience.org/library/papers/29140691 | PubMed |
| 10 | 25237858 | Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates. | Chem Biol | 2014 | https://conductscience.org/library/papers/25237858 | PubMed |
| 11 | 30212196 | Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs. | J Med Chem | 2019 | https://conductscience.org/library/papers/30212196 | PubMed |
| 12 | 22537178 | Charting, navigating, and populating natural product chemical space for drug discovery. | J Med Chem | 2012 | https://conductscience.org/library/papers/22537178 | PubMed |
| 13 | 23925671 | Matching the power of high throughput screening to the chemical diversity of natural products. | Nat Prod Rep | 2013 | https://conductscience.org/library/papers/23925671 | PubMed |
| 14 | 7903979 | The taxol supply crisis. New NCI policies for handling the large-scale production of novel natural product anticancer and anti-HIV agents. | J Nat Prod | 1993 | https://conductscience.org/library/papers/7903979 | PubMed |
| 15 | 24811496 | Patenting natural products just got harder. | Nat Biotechnol | 2014 | https://conductscience.org/library/papers/24811496 | PubMed |
| 16 | 24650394 | Emerging R and D law: the Nagoya Protocol and its implications for researchers. | ACS Chem Biol | 2014 | https://conductscience.org/library/papers/24650394 | PubMed |
| 17 | 32221504 | Why a landmark treaty to stop ocean biopiracy could stymie research. | Nature | 2020 | https://conductscience.org/library/papers/32221504 | PubMed |
| 18 | 17803898 | Molecular understanding and modern application of traditional medicines: triumphs and trials. | Cell | 2007 | https://conductscience.org/library/papers/17803898 | PubMed |
| 19 | 28685762 | Opportunities and challenges in phenotypic drug discovery: an industry perspective. | Nat Rev Drug Discov | 2017 | https://conductscience.org/library/papers/28685762 | PubMed |
| 20 | 27980341 | Induced pluripotent stem cell technology: a decade of progress. | Nat Rev Drug Discov | 2017 | https://conductscience.org/library/papers/27980341 | PubMed |
Cited by2,263
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3,505 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42979297 | Anti-HIV-1 potential of Tinospora cordifolia extracts: Multi-targeted viral inhibition and immune landscape modulation. | J Tradit Complement Med | 2026 | https://conductscience.org/library/papers/42979297 | PubMed |
| 42973815 | Inhibition of cytochrome P450 activities by juglone in human and rat liver microsomes: kinetic characterization and implications for natural product-drug interaction assessment. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42973815 | PubMed |
| 42972463 | The therapeutic landscape of cannabidiol: a systematic review of molecular mechanisms, clinical efficacy in oncology and neurology, and regulatory changes. | J Cannabis Res | 2026 | https://conductscience.org/library/papers/42972463 | PubMed |
| 42972149 | From structure prediction to ligand-target recognition: expanding the reach of AlphaFold in natural product research. | Nat Prod Bioprospect | 2026 | https://conductscience.org/library/papers/42972149 | PubMed |
| 42964358 | Clitoria ternatea as a phytopharmacological resource: plant metabolites, mechanistic evidence, translational prospects, and safety considerations. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42964358 | PubMed |
| 42962018 | Crystalline three-dimensional membranes enable chromatography-free purification of natural products. | Sci Adv | 2026 | https://conductscience.org/library/papers/42962018 | PubMed |
| 42957659 | Omaveloxolone functions as a molecular crowbar-like degrader of STING to alleviate aging-related inflammation. | Nat Commun | 2026 | https://conductscience.org/library/papers/42957659 | PubMed |
| 42948731 | AI-based strategies for diagnosis and therapeutic discovery in pulmonary fibrosis. | Chin Herb Med | 2026 | https://conductscience.org/library/papers/42948731 | PubMed |
| 42945003 | Isolation and structure elucidation of pyridinium-type metabolites from the sponge Agelas nakamurai. | J Nat Med | 2026 | https://conductscience.org/library/papers/42945003 | PubMed |
| 42943825 | Physicochemical Characterization of Liposomal Bilayer Models Loaded with Trans-4-(4'-hydroxy-3'-methoxyphenyl)-5-(1-iodoethyl)dihydrofuran-2-one. | Molecules | 2026 | https://conductscience.org/library/papers/42943825 | PubMed |
| 42943732 | Exploring the Underlying Molecular Mechanisms of Chaetomugilin Q in Breast Cancer Using Network Pharmacology, Molecular Docking, and Bioinformatics. | Molecules | 2026 | https://conductscience.org/library/papers/42943732 | PubMed |
| 42943616 | Genomic Analysis and Advanced Mining of Photorhabdus Isolates Reveal Cryptic Polyketide Synthase Clusters and Potent Anti-Staphylococcal Activity. | Microorganisms | 2026 | https://conductscience.org/library/papers/42943616 | PubMed |
| 42943487 | Immunomodulatory and Metabolic Effects of Ginsenosides Rg1/Rb1 in IBD, RA, and MASLD: Targeting Gut Microbiota-Autoimmunity Axis. | Microorganisms | 2026 | https://conductscience.org/library/papers/42943487 | PubMed |
| 42943348 | A Pathway-Driven Computational Drug Discovery Framework Integrating Machine Learning and Virtual Screening for Identification of Anti-Rheumatoid Arthritis Natural Small Molecules. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943348 | PubMed |
| 42943265 | Machine Learning for Screening Bioactive Compounds in Traditional Chinese Medicine: Computational Prediction, Multi-Omics Integration, and Clinical Translation Potential. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943265 | PubMed |
| 42943257 | Mechanisms and Therapeutic Advances of Natural Products Regulating Non-Coding RNAs in Cancer. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943257 | PubMed |
| 42943233 | Biological Effects of Umbelliferone in MCF-7 Breast Cancer Cells: Integrated In Vitro and Computational Analyses. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943233 | PubMed |
| 42943058 | Development of an Efficient Agrobacterium-Mediated Transformation Protocol for the Tetraploid Medicinal and Vegetable Species Solanum villosum Mill. | Plants (Basel) | 2026 | https://conductscience.org/library/papers/42943058 | PubMed |
| 42942765 | Phytosomal Delivery of Natural Bioactives: Advancing Bioavailability, Targeted Drug Delivery, and Clinical Translation. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42942765 | PubMed |
| 42942737 | LC-MS/MS Quantification of the Anti-Tuberculosis Macrolide Arenicolide A in Rat Plasma: Method Validation and Pharmacokinetic Application. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42942737 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| EREG | 2069 | PubTator's text mining | https://conductscience.org/library/genes/2069 | NCBI Gene |
| KEAP1 | 9817 | PubTator's text mining | https://conductscience.org/library/genes/9817 | NCBI Gene |
| NFE2L2 | 4780 | PubTator's text mining | https://conductscience.org/library/genes/4780 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33510482
GET https://conductscience.org/api/papers/v1/33510482/references?page=2